Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT01905657
Status:
COMPLETED
Last Update Posted:
2021-10-06
First Post:
2013-07-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)
Sponsor:
Merck Sharp & Dohme LLC
Organization: